Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The company's proprietary technology development program culminated in the world's first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious infections.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/05/22 | $100,000,000 | Series E |
Artiman Ventures Blue Water Life Science Fund Cedars-Sinai Medical Center Healthcare of Ontario Pension Plan John Doerr ND Capital Nissim Capital Ping An Ventures  Pitango Venture Capital | undisclosed |
| 06/30/22 | $35,000,000 | Series E Extension |
Lightrock | undisclosed |
| 06/17/25 | $65,000,000 | Venture |
Blue Water Life Science Fund Catalio Capital Management Cedars-Sinai Medical Center John Doerr ND Capital Pitango Venture Capital | undisclosed |
